欧林生物：公司已于2025年5月底完成了重组金葡菌疫苗全部入组

Group 1 - The company has completed the enrollment for the restructured gold-staphylococcus vaccine by the end of May 2025 and is actively advancing data cleaning and related research work [1] - Based on current progress, the company expects to complete the unblinding process in the first half of 2026 [1] - The clinical trial progress and results may be influenced by various factors, and the final outcomes will be based on the company's public information [1]